Overview

Novel Treatment for Diastolic Heart Failure in Women

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironolactone can cause the patient's condition to improve.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Treatments:
Spironolactone